n
In a move that underscores its growing ambition in the digital health space, Tencent has received regulatory approval for its first digital therapeutics software, “Tencent Brain Training.” The software, designed to treat mild cognitive impairment, has been granted a medical device registration certificate, marking a significant milestone for the tech giant.
This marks Tencent’s sixth medical device registration, further solidifying its commitment to developing healthcare solutions.
The “Tencent Brain Training” software utilizes gamified cognitive training methods, a strategy that aligns with established evidence-based medical principles. The platform is designed to engage patients via interactive tasks, aiming to improve cognitive abilities in those experiencing mild impairments.
The regulatory approval translates into a key shift: physicians can now prescribe “Tencent Brain Training” as a treatment option for patients with mild cognitive impairment.
The digital therapy approach leverages the brain’s neuroplasticity, encouraging the rewiring and strengthening of cognitive functions through engaging, game-like experiences. This offers a non-pharmacological and non-surgical intervention, focusing on improving patients’ quality of life.
The initiative targets a significant and often overlooked health concern. Early signs of cognitive decline, often dismissed as simple forgetfulness, can be indicative of deeper issues.
The market for such interventions is substantial, with approximately 38.77 million elderly individuals grappling with mild cognitive impairment in China. Furthermore, around 38% of these patients could progress to develop Alzheimer’s disease within five years.
By targeting this demographic, “Tencent Brain Training” aims to address a pressing healthcare challenge with the potential to reshape treatment paradigms.
Original article, Author: Tobias. If you wish to reprint this article, please indicate the source:https://aicnbc.com/3118.html
